Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
49.54
-0.11 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Royalty Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 29,368 | 16,509 | 11,334 | 12,497 | 17,432 | 17,116 | Upgrade
|
| Market Cap Growth | 112.13% | 45.66% | -9.30% | -28.31% | 1.85% | -11.89% | Upgrade
|
| Enterprise Value | 37,701 | 27,726 | 21,332 | 21,132 | 27,333 | 26,687 | Upgrade
|
| Last Close Price | 49.54 | 38.44 | 24.75 | 26.44 | 36.25 | 35.90 | Upgrade
|
| PE Ratio | 27.81 | 21.41 | 13.20 | 11.01 | 407.00 | 27.62 | Upgrade
|
| Forward PE | 9.71 | 7.70 | 6.10 | 7.47 | 10.32 | 13.00 | Upgrade
|
| PS Ratio | 12.35 | 6.94 | 5.01 | 5.31 | 7.79 | 7.48 | Upgrade
|
| PB Ratio | 3.28 | 1.70 | 1.10 | 1.24 | 1.83 | 1.67 | Upgrade
|
| P/TBV Ratio | 5.29 | 2.97 | 1.63 | 1.92 | 3.11 | 2.97 | Upgrade
|
| P/OCF Ratio | 11.80 | 6.63 | 4.09 | 4.18 | 8.13 | 8.48 | Upgrade
|
| PEG Ratio | 1.04 | 0.79 | 2.14 | 2.65 | 0.94 | 1.12 | Upgrade
|
| EV/Sales Ratio | 15.85 | 11.66 | 9.42 | 8.98 | 12.22 | 11.66 | Upgrade
|
| EV/EBITDA Ratio | 24.12 | 17.74 | - | 14.11 | 29.44 | 18.36 | Upgrade
|
| EV/EBIT Ratio | 24.17 | 17.78 | 16.51 | 14.16 | 29.62 | 18.65 | Upgrade
|
| Debt / Equity Ratio | 0.92 | 0.92 | 0.74 | 0.61 | 0.75 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 5.74 | 5.74 | - | 4.10 | 7.66 | 4.88 | Upgrade
|
| Net Debt / Equity Ratio | 0.86 | 0.86 | 0.64 | 0.56 | 0.56 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.33 | 5.33 | - | 3.77 | 5.79 | 3.38 | Upgrade
|
| Asset Turnover | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 | 0.14 | Upgrade
|
| Quick Ratio | 2.39 | 2.39 | 1.43 | 7.78 | 2.11 | 16.77 | Upgrade
|
| Current Ratio | 2.40 | 2.40 | 1.44 | 7.90 | 2.19 | 16.81 | Upgrade
|
| Return on Equity (ROE) | 13.20% | 13.20% | 13.03% | 17.34% | 2.33% | 12.32% | Upgrade
|
| Return on Assets (ROA) | 5.15% | 5.15% | 4.67% | 5.62% | 3.36% | 5.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 8.20% | 7.60% | 9.20% | 5.90% | 8.20% | Upgrade
|
| Earnings Yield | 2.63% | 4.67% | 7.58% | 9.08% | 0.25% | 3.62% | Upgrade
|
| Dividend Yield | 1.90% | 2.29% | 3.39% | 3.03% | 2.10% | 1.89% | Upgrade
|
| Payout Ratio | 51.08% | 49.06% | 43.83% | 31.57% | 778.21% | 46.02% | Upgrade
|
| Buyback Yield / Dilution | 4.99% | 4.99% | 1.46% | -37.66% | -5.59% | -10.48% | Upgrade
|
| Total Shareholder Return | 6.89% | 7.28% | 4.85% | -34.63% | -3.49% | -8.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.